Inventor · disambiguated record
Markus Reschke
Also filed as: RESCHKE MARKUS · RESCHKE MARKUS OLIVER
1 granted patent·9 pending applications·1 citations·filing 2009–2025
17Inventor score
Top patents by PatentIndex Score
10 records- 0172US11198726B2Anti-cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Granted Dec 14, 2021·1 cites·6 claims
- 0261US2022340651A1Anti cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2021·Application pending·0 cites
- 0359US2023025452A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2022·Application pending·0 cites
- 0454US2025090699A1Fap targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2024·Application pending·0 cites
- 0546US2011033482A1Her3 as a determinant for the prognosis of melanomaMAX PLANCK GESELLSCHAFT·Filed 2009·Application pending·0 cites
- 0646US2025332300A1Her2 targeting cyclic peptides and conjugates thereofNOVARTIS AG·Filed 2025·Application pending·0 cites
- 0743US2020101079A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 0841US2015079590A1Characterization and analysis of the composition and dynamics of the mammalian riboproteomeBETH ISRAEL HOSPITAL·Filed 2014·Application pending·0 cites
- 0938US2020046684A1Anticancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
- 1035US2020239559A1Anti igf, anti pd-1, anti-cancer combination therapyBOEHRINGER INGELHEIM INT·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Markus Reschke files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →